Viprakasit, V. Et Al. 2023. Patient preference for deferasirox film-coated versus dispersible tablet formulation: a sequential-design phase 2 study in patients with thalassemia. Annals of Hematology , vol.102, no.8 , 2039-2049.

Viprakasit, V., Hamdy, M. M., Hassab, H. M. A., Sherief, L. M., Al-Bagshi, M., Khattab, M., ... Chuncharunee, S.(2023). Patient preference for deferasirox film-coated versus dispersible tablet formulation: a sequential-design phase 2 study in patients with thalassemia. Annals of Hematology , vol.102, no.8, 2039-2049.

Viprakasit, Vip Et Al. "Patient preference for deferasirox film-coated versus dispersible tablet formulation: a sequential-design phase 2 study in patients with thalassemia," Annals of Hematology , vol.102, no.8, 2039-2049, 2023

Viprakasit, Vip Et Al. "Patient preference for deferasirox film-coated versus dispersible tablet formulation: a sequential-design phase 2 study in patients with thalassemia." Annals of Hematology , vol.102, no.8, pp.2039-2049, 2023

Viprakasit, V. Et Al. (2023) . "Patient preference for deferasirox film-coated versus dispersible tablet formulation: a sequential-design phase 2 study in patients with thalassemia." Annals of Hematology , vol.102, no.8, pp.2039-2049.

@article{article, author={Vip Viprakasit Et Al. }, title={Patient preference for deferasirox film-coated versus dispersible tablet formulation: a sequential-design phase 2 study in patients with thalassemia}, journal={Annals of Hematology}, year=2023, pages={2039-2049} }